NSE has sought clarification from several listed companies regarding unusual price and volume activity

Traders Union
All News
Financial News
NSE listed companies clarification

Highlights

On July 15-16, 2026, NSE sought clarification from Archean Chemical Industries, Hardwyn India, Jindal Worldwide, and Wanbury Limited regarding unusual trading activities.
Clarifications are still pending in cases of unusual price or volume movements in several companies, including Crop Life Science, Global Surfaces, Identical Brains Studios, Liberty Shoes, Redtape, and Responsive Industries.
NSE has sought clarification from Pfizer regarding media reports about the suspension of Premarin vaginal cream, which has raised concerns in the market about menopause care.

This article was translated from the original. Read the original version by our correspondent here.

Exchange Inquiries and Available Clarifications

According to the National Stock Exchange of India, Archean Chemical Industries Limited, Hardwyn India Limited, Jindal Worldwide Limited, and Wanbury Limited were sent letters seeking clarification on recent unusual activities, and the responses from these companies are available in the corporate filings and announcements section on the NSE website. Archean Chemical Industries Limited was sent a letter on July 15, 2026, while Hardwyn India Limited, Jindal Worldwide Limited, and Wanbury Limited were contacted on July 16, 2026.

Archean Chemical Industries Limited and Jindal Worldwide Limited saw a significant increase in volume. Hardwyn India Limited and Wanbury Limited recorded notable price surges or declines, after which the exchange sought clarification to protect investor interests and provide updated information to the market.

Companies Whose Responses Are Still Pending

Besides Crop Life Science Limited, Global Surfaces Limited, Identical Brains Studios Limited, and Wanbury Limited, the exchange has also acted on unusual activity in several other companies, though responses are still pending in some cases. Crop Life Science Limited, Global Surfaces Limited, and Identical Brains Studios Limited saw significant price increases or declines, while Liberty Shoes Limited, Redtape Limited, and Responsive Industries Limited recorded notable increases in volume.

In the case of Pfizer, the exchange has sought clarification from the company regarding a media report stating that it has suspended Premarin vaginal cream in India, raising concerns about menopause care. The company's response is also awaited in this matter, and the exchange has stated that its aim is to verify the accuracy of the information and protect investors' interests.

Our previous report on NSE seeking clarifications from listed companies regarding unusual share price or volume activity and, in some cases, confirmation of media reports mentioned that several companies were sent letters asking them to clarify the factual situation. That update also noted that where responses were received, the clarifications were made public in the corporate filings/announcements section of the NSE website, while responses in other cases remained pending.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.